Lowering blood pressure for cardiovascular risk reduction: Moving the goalposts or spreading the net?

Journal of Hypertension

Volumn 20, Issue 10, 2002, Pages 1945-1948

  Webster, John ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDAPAMIDE; PERINDOPRIL; ANTIHYPERTENSIVE AGENT;

BLOOD PRESSURE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DIAGNOSTIC TEST; EVIDENCE BASED MEDICINE; HIGH RISK POPULATION; HYPERTENSION; ISCHEMIC HEART DISEASE; NOTE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STATISTICS; STROKE; CARDIOVASCULAR DISEASE; DRUG EFFECT; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK REDUCTION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; EVIDENCE-BASED MEDICINE; HUMANS; HYPERTENSION; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 0036807548     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200210000-00011     Document Type: Note

References (28)

1. Law MR, Wald NJ. Risk factor thresholds: Their existence under scrutiny. BMJ 2002; 324:1570-1576.
2. Voko Z, Bots ML, Hofman A, Koudstaal PJ, Witteman JC, Breteler MM. J-shaped relation between blood pressure and stroke in treated hypertension. Hypertension 1999; 34:1181-1185.
3. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke and coronary heart disease. 1. Prolonged differences in blood pressure: Prospective observational studies corrected for regression dilution bias. Lancet 1990; 335:765-774.
4. Webster J, Petrie JC, Jeffers TA, Lovell HG. Accelerated hypertension - Patterns of mortality and clinical factors affecting outcome in treated patients. Q J Med 1993; 86:485-493.
5. Veterans Administration Study Group on Antihypertensive Agents. Effects of treatment on mortality in hypertension. Results in patients with diastolic blood pressure averaging 115 through 129 mmHg. JAMA 1967; 202:1028-1034.
6. Veterans Administration Cooperative Study Group. Effects of treatment on morbidity in hypertension II: Results in patients with diastolic blood pressure averaging 90 through 114 mmHg. JAMA 1970; 213:1143-1152.
7. Medical Research Council Working Party. MRC trial in mild hypertension: Principal results. BMJ 1985; 291:97-104.
8. Thijs L, Fagard R, Lijnen P, Staessen J, VanHoof R, Amery A. A meta-analysis of outcome trials in elderly hypertensives. J Hypertens 1992; 10:1103-1109.
9. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, et al., for the Systolic Hypertension in Europe (SYST-EUR) Trial Investigators. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. Lancet 1997; 350:757-764.
10. The SHEP Co-operative Group. Prevention of stroke by antihypertensive drug treatment in older patients with isolated systolic hypertension. JAMA 1991; 265:3255-3264.
11. Alderman MH. Blood pressure management: Individualised treatment based on absolute risk and the potential for benefit. Ann Intern Med 1993; 119:329-335.
12. Guidelines Subcommittee. 1999 World health organisation-international society of hypertension guideleines for management of hypertension. J Hypertens 1999; 17:151-183.
13. The sixth report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. Arch Intern Med 1997; 157:2413-2446.
14. Ramsay LE, Williams B, Johnston DG, MacGregor GA, Poston L, Potter JF, et al. Guidelines for the management of hypertension; report on third working party of the British Hypertension Society. J Hum Hypertens 1999; 13:569-592.
15. SIGN Guideline 49: Hypertension in Older People. Scottish Intercollegiate Guidelines Network. http://www.sign.ac.uk [Accessed January 2001]
16. Vanan RS, Larson MG, Leip EP, Kannel WB, Levy D. Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: A cohort study. Lancet 2001; 358:1682-1686.
17. Yeo KR, Yeo WW. Should we treat high-normal blood pressure? J Hypertens 2002; 20:2057-2062.
18. Anderson KR, Wilson PWF, Odell PM, Kannel WP. An updated coronary risk profile. A standard for health professionals. Circulation 1991; 83:356-362.
19. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or ischaemic attack. Lancet 2001; 358:1033-1041.
20. The HOPE Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardovascular events of high-risk patients. N Engl J Med 2000; 342:145-153.
21. Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood pressure lowering drugs: Results of prospectively designed overviews of randomised trials. Lancet 2000; 356:1955-1964.
22. Staessen JA, Wang J-G, Thijs L. Cardiovascular protection and blood pressure reduction: A meta-analysis. Lancet 2001; 358:1305-1315.
23. The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet 1994; 344:1383-1389.
24. Shepherd J, Cobbe SM, Ford I, Isles CJ, Lorimer AR, McFarlane PW, et al., for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia. J Engl J Med 1995; 333:1301-1307.
25. Sacks FM, Pfeffer MA, Moya LA, Pouleau JL, Rutherford JD, Cole TG, et al., for the Cholesterol and Recurrent Events trial investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol. N Engl J Med 1996; 335:1001-1009.
26. The Long-term intervention with Pravastatin in Ischaemic Disease (LIPID) study group. Prevention of cardiovascular events with pravastatin in patients with coronary disease and a broad range of initial cholesterol levels. N Engl J Med 1998; 339:1344-1357.
27. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals; a randomised placebo-controlled trial. Lancet 2002; 360:7-22.
28. US Department of Health and Human Services. Agency for Health Care Policy and Research. Acute Pain Management: Operative or Medical Procedures and Trauma. Clinical Practice Guideline no. 1. AHCPR Publication no. 92-0023. Rockville, MD: The Agency; 1993. p. 107.